RyMed Technologies
Pre-clinicalThe InVision-Plus® with Neutral Advantage Technology sets the new standard in needleless I.V. connectors, combining patented design and neutral fluid displacement features into a product that can be effectively swabbed and flushed.
Founded
2003
Focus
Drug DeliveryMedical Devices
About
The InVision-Plus® with Neutral Advantage Technology sets the new standard in needleless I.V. connectors, combining patented design and neutral fluid displacement features into a product that can be effectively swabbed and flushed.
Company Info
TypePrivate
Founded2003
LocationFranklin, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile